For citations:
NEW INDICATION REGISTERED FOR THE MEDICINE FORCIGA® (DAPAGLIFLOZIN): CHRONIC KIDNEY DISEASE. Diabetes mellitus. 2021;24(5):487. (In Russ.)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
